Palumbo Wealth Management’s Assembly Biosciences ASMB Stock Holding History

Palumbo Wealth Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Buy	19,865 +222	+1%	+$6.04K	0.11%	136
2026 Q1	$545K	Sell	19,643 -17,662	-47%	-$504K	0.13%	116
2025 Q4	$1.27M	Buy	37,305 +2,507	+7%	+$80.7K	0.31%	61
2025 Q3	$891K	Buy	34,798 +16,131	+86%	+$354K	0.28%	65
2025 Q2	$338K	Buy	18,667 +681	+4%	+$8.98K	0.1%	133
2025 Q1	$172K	Buy	17,986 +6,559	+57%	+$85.8K	0.06%	171
2024 Q4	$180K	Buy	+11,427	New	+$184K	0.07%	156
2024 Q1	–	Sell	-840	Closed	-$8.26K	–	141
2023 Q4	$8.26K	Buy	+840	New	+$7.99K	﹤0.01%	123

Other funds holding ASMB

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Palumbo Wealth Management's ASMB Position: Q2 2026 in Review

Palumbo Wealth Management increased its Assembly Biosciences (ASMB) stake by 1.1% in Q2 2026, buying an estimated $6.04K and bringing the position to 19,865 shares worth $546K. The position accounts for 0.11% of the portfolio, ranked #136.

Palumbo Wealth Management first reported a position in ASMB in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.27M in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

Palumbo Wealth Management held 19,865 shares of Assembly Biosciences worth $546K as of Q2 2026.
Palumbo Wealth Management bought 222 Assembly Biosciences shares in Q2 2026, an estimated $6.04K.
Assembly Biosciences made up 0.11% of Palumbo Wealth Management's portfolio in Q2 2026, its #136 holding.
Palumbo Wealth Management first reported a position in Assembly Biosciences in Q4 2023 and has held it in 8 quarters since.
Palumbo Wealth Management's Assembly Biosciences position peaked at $1.27M in Q4 2025.
93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.